Turkey herpesvirus-infectious bursal disease (HVT-IBD) vector vaccine-field experience in commercial broilers in Egypt
Herrmann Andreas, Negm Hazem & Sultan Hesham
The objectives of the presented study in commercial broilers was to evaluate in field conditions in Egypt the benefits of the newly introduced HVT -IBD vector vaccine expressing the VP2 of the Faragher 52/70 virus strain , VAXXITEK™ HVT +IBD (VAXXITEK is a registered trademark of Merial in the United States of America and elsewhere) injected at day-old in the hatcheries, as compared to a traditional IBD vaccination program using a live IBD vaccine administered by drinking water in the poultry houses. Evaluation of efficacy in context of field wiBD virus challenge was performed. The impact of the day-old vaccination using the HVT -IBD vector vaccine on the zootechnical parameters of broiler flock performance monitoring was then recorded. The economical benefit of day-old HVT-IBD vector vaccine application on chicken meat production was then assessed.
Scientific Literature & Other Materials
Want to dig deeper? Browse published research on a range of poultry diseases and products, plus our equipment brochures, website articles, and more.
Product background info, vaccination equipment demos, and customer testimonials—explore all these and others from our video collection.